StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Neogen price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Neogen's price to sales ratio was 2.9× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 1.1× to 10.0×, with a median of 3.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.9×+1.2
2025Dec 31, 20251.7×−1.2
2024Dec 31, 20242.9×−1.8
2023Dec 29, 20234.7×+1.6
2022Dec 30, 20223.1×−6.9
2021Dec 31, 202110.0×+0.1
2020Dec 31, 20209.9×+1.6
2019Dec 31, 20198.2×+0.9
2018Dec 31, 20187.3×−1.1
2017Dec 29, 20178.4×−1.6
2016Dec 30, 201610.1×+0.4
2015Dec 31, 20159.7×+0.2
2014Dec 31, 20149.5×−0.7
2013Dec 31, 201310.2×+2.6
2012Dec 31, 20127.6×+2.2
2011Dec 30, 20115.4×−3.5
2010Dec 31, 20109.0×–

More Neogen figures

See a number that looks wrong?